Relay Therapeutics Executive Sells $100k in Shares to Cover RSU Taxes; Company Posts Positive Clinical and Analyst Updates
Relay Therapeutics executive Peter Rahmer sold 13,038 shares of the company’s common stock on January 27 and 28, 2026, generating roughly $100,473 to meet tax withholding obligations tied to vested restricted stock units. The transactions came as Relay’s stock traded near the lower end of the sale range and followed a year that has seen significant…